SpaceX has officially joined the Nasdaq-100 index, less than a month after its initial public offering (IPO) in June. The company, led by Elon Musk, became one of the fastest inclusions ever into the tech-heavy index following revised rules that waived the typical three-month waiting period.
Key Takeaways
SpaceX has officially joined the Nasdaq-100 index less than a month after its initial public offering (IPO). Despite this milestone, shares have fallen below their debut price. The company's inclusion in the index required revisions to Nasdaq's rules and has sparked mixed reactions from analysts.
- SpaceX joins Nasdaq-100 under revised rules
- Shares fall below IPO price post-inclusion
- Analysts divided on SpaceX's future prospects
- Starship rocket seen as key growth driver
⚖
▼Source Claims Check
1 Difference FoundAll 5 publishers report consistent facts across 2 key claims. 1 point of difference noted.
| Claim | Status | Reason | |
|---|---|---|---|
| Spacex's Stock Price Post-inclusion | 1 Difference | Different reports of the stock price post-inclusion | ▼ |
| Spacex Nasdaq-100 Inclusion Date | Broad Agreement | Joined July 8, less than a month after IPO | |
| Analyst Ratings On Spacex | Broad Agreement | Mostly bullish with high price targets, some neutral or sell ratings |
Spacex's Stock Price Post-inclusion
▼Different reports of the stock price post-inclusion
Spacex Nasdaq-100 Inclusion Date
Broad AgreementJoined July 8, less than a month after IPO
Analyst Ratings On Spacex
Broad AgreementMostly bullish with high price targets, some neutral or sell ratings
This analysis is AI-generated and may not perfectly represent each source's reporting. Always read the original articles for full context.
The inclusion required index funds and exchange-traded funds tied to the Nasdaq-100 to buy SpaceX shares. However, despite this milestone, SpaceX's stock has fallen below its debut price of $150 per share, closing at $148 on Wednesday, according to CNBC.
Analysts have offered mixed reactions to SpaceX's prospects. Most brokerages initiated coverage with bullish ratings and high price targets. Morgan Stanley rated the stock "overweight" with a $300 target, while Bernstein and RBC both gave "outperform" ratings with targets of $239 and $225 respectively.
However, not all analysts are optimistic. MoffettNathanson initiated coverage with a neutral rating, and CFRA recommended selling shares. The stock's recent slide reflects broader concerns about the longevity of the AI boom and high expectations for tech stocks.
How this summary was created
This summary synthesizes reporting from 5 independent publishers using AI. All sources are cited and linked below. NewsBalance is a news aggregator and media literacy tool, not a news publisher. AI-generated content may contain errors or inaccuracies — always verify important information with the original sources.